WELL HEALTH TECHNOLOGIES COR (WELL.CA) Fundamental Analysis & Valuation

TSX:WELL • CA94947L1022

Current stock price

4.3 CAD
+0.15 (+3.61%)
Last:

This WELL.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. WELL.CA Profitability Analysis

1.1 Basic Checks

  • WELL had positive earnings in the past year.
  • In the past year WELL had a positive cash flow from operations.
  • In multiple years WELL reported negative net income over the last 5 years.
  • In the past 5 years WELL always reported a positive cash flow from operatings.
WELL.CA Yearly Net Income VS EBIT VS OCF VS FCFWELL.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M

1.2 Ratios

  • WELL has a Return On Assets (-0.35%) which is comparable to the rest of the industry.
  • With a decent Return On Equity value of -0.85%, WELL is doing good in the industry, outperforming 61.54% of the companies in the same industry.
  • With a decent Return On Invested Capital value of 4.48%, WELL is doing good in the industry, outperforming 69.23% of the companies in the same industry.
Industry RankSector Rank
ROA -0.35%
ROE -0.85%
ROIC 4.48%
ROA(3y)0.49%
ROA(5y)-0.37%
ROE(3y)0.97%
ROE(5y)-0.81%
ROIC(3y)N/A
ROIC(5y)N/A
WELL.CA Yearly ROA, ROE, ROICWELL.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500 -500 -1K

1.3 Margins

  • With a decent Operating Margin value of 6.62%, WELL is doing good in the industry, outperforming 69.23% of the companies in the same industry.
  • In the last couple of years the Operating Margin of WELL has grown nicely.
  • WELL has a better Gross Margin (44.20%) than 69.23% of its industry peers.
  • In the last couple of years the Gross Margin of WELL has remained more or less at the same level.
Industry RankSector Rank
OM 6.62%
PM (TTM) N/A
GM 44.2%
OM growth 3Y16.22%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.05%
GM growth 5Y0.91%
WELL.CA Yearly Profit, Operating, Gross MarginsWELL.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -500 -1K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. WELL.CA Health Analysis

2.1 Basic Checks

  • WELL has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • The number of shares outstanding for WELL has been increased compared to 1 year ago.
  • WELL has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, WELL has a worse debt to assets ratio.
WELL.CA Yearly Shares OutstandingWELL.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M
WELL.CA Yearly Total Debt VS Total AssetsWELL.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

2.2 Solvency

  • WELL has an Altman-Z score of 1.33. This is a bad value and indicates that WELL is not financially healthy and even has some risk of bankruptcy.
  • WELL has a Altman-Z score (1.33) which is comparable to the rest of the industry.
  • WELL has a debt to FCF ratio of 7.56. This is a slightly negative value and a sign of low solvency as WELL would need 7.56 years to pay back of all of its debts.
  • The Debt to FCF ratio of WELL (7.56) is better than 61.54% of its industry peers.
  • WELL has a Debt/Equity ratio of 0.70. This is a neutral value indicating WELL is somewhat dependend on debt financing.
  • WELL's Debt to Equity ratio of 0.70 is fine compared to the rest of the industry. WELL outperforms 76.92% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.7
Debt/FCF 7.56
Altman-Z 1.33
ROIC/WACC0.55
WACC8.09%
WELL.CA Yearly LT Debt VS Equity VS FCFWELL.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M 800M

2.3 Liquidity

  • WELL has a Current Ratio of 1.03. This is a normal value and indicates that WELL is financially healthy and should not expect problems in meeting its short term obligations.
  • WELL has a Current ratio of 1.03. This is in the better half of the industry: WELL outperforms 76.92% of its industry peers.
  • A Quick Ratio of 1.03 indicates that WELL should not have too much problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 1.03, WELL is in the better half of the industry, outperforming 76.92% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.03
Quick Ratio 1.03
WELL.CA Yearly Current Assets VS Current LiabilitesWELL.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. WELL.CA Growth Analysis

3.1 Past

  • The earnings per share for WELL have decreased strongly by -26.67% in the last year.
  • The Revenue has grown by 52.25% in the past year. This is a very strong growth!
  • Measured over the past years, WELL shows a very strong growth in Revenue. The Revenue has been growing by 94.58% on average per year.
EPS 1Y (TTM)-26.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%766.67%
Revenue 1Y (TTM)52.25%
Revenue growth 3Y35%
Revenue growth 5Y94.58%
Sales Q2Q%63.9%

3.2 Future

  • Based on estimates for the next years, WELL will show a very strong growth in Earnings Per Share. The EPS will grow by 40.64% on average per year.
  • The Revenue is expected to grow by 8.14% on average over the next years. This is quite good.
EPS Next Y172%
EPS Next 2Y89.9%
EPS Next 3Y40.64%
EPS Next 5YN/A
Revenue Next Year11.69%
Revenue Next 2Y9.2%
Revenue Next 3Y8.14%
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
WELL.CA Yearly Revenue VS EstimatesWELL.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B
WELL.CA Yearly EPS VS EstimatesWELL.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 0.2 -0.2 0.4

More info and screens

Find the best growth stocksShow best growing peers

6

4. WELL.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 39.09, the valuation of WELL can be described as expensive.
  • Based on the Price/Earnings ratio, WELL is valued a bit cheaper than the industry average as 69.23% of the companies are valued more expensively.
  • WELL's Price/Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 27.42.
  • Based on the Price/Forward Earnings ratio of 14.37, the valuation of WELL can be described as correct.
  • 84.62% of the companies in the same industry are more expensive than WELL, based on the Price/Forward Earnings ratio.
  • WELL's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.24.
Industry RankSector Rank
PE 39.09
Fwd PE 14.37
WELL.CA Price Earnings VS Forward Price EarningsWELL.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, WELL is valued cheaply inside the industry as 92.31% of the companies are valued more expensively.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of WELL indicates a somewhat cheap valuation: WELL is cheaper than 69.23% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 11.69
EV/EBITDA 8.78
WELL.CA Per share dataWELL.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4

4.3 Compensation for Growth

  • WELL's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as WELL's earnings are expected to grow with 40.64% in the coming years.
PEG (NY)0.23
PEG (5Y)N/A
EPS Next 2Y89.9%
EPS Next 3Y40.64%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. WELL.CA Dividend Analysis

5.1 Amount

  • No dividends for WELL!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

WELL.CA Fundamentals: All Metrics, Ratios and Statistics

WELL HEALTH TECHNOLOGIES COR

TSX:WELL (4/24/2026, 7:00:00 PM)

4.3

+0.15 (+3.61%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)03-19
Earnings (Next)05-13
Inst Owners3.71%
Inst Owner ChangeN/A
Ins Owners22.55%
Ins Owner ChangeN/A
Market Cap1.10B
Revenue(TTM)1.40B
Net Income(TTM)-7.36M
Analysts82
Price Target7.21 (67.67%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)27.38%
Min EPS beat(2)-32.99%
Max EPS beat(2)87.74%
EPS beat(4)1
Avg EPS beat(4)-170.63%
Min EPS beat(4)-696.08%
Max EPS beat(4)87.74%
EPS beat(8)3
Avg EPS beat(8)2157.64%
EPS beat(12)3
Avg EPS beat(12)1034.47%
EPS beat(16)4
Avg EPS beat(16)745.25%
Revenue beat(2)0
Avg Revenue beat(2)-2.78%
Min Revenue beat(2)-3.29%
Max Revenue beat(2)-2.26%
Revenue beat(4)1
Avg Revenue beat(4)-1.3%
Min Revenue beat(4)-3.29%
Max Revenue beat(4)1.59%
Revenue beat(8)2
Avg Revenue beat(8)-2.19%
Revenue beat(12)5
Avg Revenue beat(12)-0.86%
Revenue beat(16)8
Avg Revenue beat(16)0%
PT rev (1m)-7.38%
PT rev (3m)-7.61%
EPS NQ rev (1m)-27.42%
EPS NQ rev (3m)-27.42%
EPS NY rev (1m)-29.32%
EPS NY rev (3m)-28.28%
Revenue NQ rev (1m)-1.35%
Revenue NQ rev (3m)-1.05%
Revenue NY rev (1m)0.13%
Revenue NY rev (3m)0.38%
Valuation
Industry RankSector Rank
PE 39.09
Fwd PE 14.37
P/S 0.78
P/FCF 11.69
P/OCF 9.01
P/B 1.27
P/tB N/A
EV/EBITDA 8.78
EPS(TTM)0.11
EY2.56%
EPS(NY)0.3
Fwd EY6.96%
FCF(TTM)0.37
FCFY8.56%
OCF(TTM)0.48
OCFY11.09%
SpS5.48
BVpS3.38
TBVpS-2.68
PEG (NY)0.23
PEG (5Y)N/A
Graham Number2.89212 (-32.74%)
Profitability
Industry RankSector Rank
ROA -0.35%
ROE -0.85%
ROCE 5.33%
ROIC 4.48%
ROICexc 4.85%
ROICexgc 134.73%
OM 6.62%
PM (TTM) N/A
GM 44.2%
FCFM 6.71%
ROA(3y)0.49%
ROA(5y)-0.37%
ROE(3y)0.97%
ROE(5y)-0.81%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y61.44%
ROICexgc growth 5YN/A
ROICexc growth 3Y39.71%
ROICexc growth 5YN/A
OM growth 3Y16.22%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.05%
GM growth 5Y0.91%
F-Score5
Asset Turnover0.67
Health
Industry RankSector Rank
Debt/Equity 0.7
Debt/FCF 7.56
Debt/EBITDA 3.22
Cap/Depr 29.72%
Cap/Sales 1.99%
Interest Coverage 3
Cash Conversion 65.37%
Profit Quality N/A
Current Ratio 1.03
Quick Ratio 1.03
Altman-Z 1.33
F-Score5
WACC8.09%
ROIC/WACC0.55
Cap/Depr(3y)21.84%
Cap/Depr(5y)16.82%
Cap/Sales(3y)1.6%
Cap/Sales(5y)1.36%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-26.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%766.67%
EPS Next Y172%
EPS Next 2Y89.9%
EPS Next 3Y40.64%
EPS Next 5YN/A
Revenue 1Y (TTM)52.25%
Revenue growth 3Y35%
Revenue growth 5Y94.58%
Sales Q2Q%63.9%
Revenue Next Year11.69%
Revenue Next 2Y9.2%
Revenue Next 3Y8.14%
Revenue Next 5YN/A
EBIT growth 1Y401.33%
EBIT growth 3Y56.9%
EBIT growth 5YN/A
EBIT Next Year111.26%
EBIT Next 3Y39.56%
EBIT Next 5YN/A
FCF growth 1Y1666.71%
FCF growth 3Y10.25%
FCF growth 5YN/A
OCF growth 1Y1092.06%
OCF growth 3Y16.77%
OCF growth 5YN/A

WELL HEALTH TECHNOLOGIES COR / WELL.CA Fundamental Analysis FAQ

What is the ChartMill fundamental rating of WELL HEALTH TECHNOLOGIES COR (WELL.CA) stock?

ChartMill assigns a fundamental rating of 5 / 10 to WELL.CA.


Can you provide the valuation status for WELL HEALTH TECHNOLOGIES COR?

ChartMill assigns a valuation rating of 6 / 10 to WELL HEALTH TECHNOLOGIES COR (WELL.CA). This can be considered as Fairly Valued.


How profitable is WELL HEALTH TECHNOLOGIES COR (WELL.CA) stock?

WELL HEALTH TECHNOLOGIES COR (WELL.CA) has a profitability rating of 5 / 10.


What is the financial health of WELL HEALTH TECHNOLOGIES COR (WELL.CA) stock?

The financial health rating of WELL HEALTH TECHNOLOGIES COR (WELL.CA) is 4 / 10.